Reuters logo
BRIEF-Mimedx files with FDA to initiate co's investigational new drug Phase 2 clinical trial for Osteoarthritis of Knee
September 19, 2017 / 2:42 PM / a month ago

BRIEF-Mimedx files with FDA to initiate co's investigational new drug Phase 2 clinical trial for Osteoarthritis of Knee

Sept 19 (Reuters) - Mimedx Group Inc

* Mimedx files with the FDA to initiate the company’s investigational new drug phase 2 clinical trial for Osteoarthritis of the knee

* Mimedx group inc - ‍company expects patient enrollment to commence by end of year​

* Mimedx group inc - ‍plans to submit a biologic license application (BLA) to FDA for TENDONITIS when company’s Plantar Fasciitis phase 3 trial completes​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below